Decision support for pancreatic cancer screening
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is testing a tool that helps people at high risk for pancreatic cancer make informed decisions about screening. It aims to support you in choosing whether and how to get screened for pancreatic cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at higher risk for pancreatic cancer, such as having a strong family history or a genetic condition that increases risk.
- You are not currently having regular pancreatic cancer screenings.
- You have been referred to or have already visited the UNC High Risk GI Cancer Clinic.
- You speak and understand English.
- You are willing and able to agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests visual tools to help surgeons make better decisions for patients with early-stage prostate or kidney cancer. It may help you and your doctor choose the best treatment.
This study tests a digital tool designed to help patients with advanced (stage IV) breast cancer make treatment decisions. The tool may help you understand your options and feel more confident discussing them with your doctor.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
This study tests a digital support program led by community health workers for people recently diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer). The program aims to help patients navigate their diagnosis and treatment.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study uses artificial intelligence to analyze tissue samples from pancreatic cancer to help predict how the disease may progress. It aims to improve treatment planning and patient care.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.